Inhibition of Pax 5 activity by expression of its DNA binding domain.
Hastings
G Z
GZ
Dept. Biochemistry, University of Sussex.
Adams
B
B
D001665:Binding Sites; D002490:Central Nervous System / Q000378:metabolism; D015500:Chloramphenicol O-Acetyltransferase / Q000096:biosynthesis; D004268:DNA-Binding Proteins / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000378:metabolism*; D018274:Electroporation; D015870:Gene Expression; D006367:HeLa Cells; D006801:Humans; D008297:Male; D009687:Nuclear Proteins / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000378:metabolism*; D051757:PAX5 Transcription Factor; D010957:Plasmids; D011994:Recombinant Proteins / Q000096:biosynthesis; D013737:Testis / Q000378:metabolism; D014157:Transcription Factors / Q000378:metabolism; D015533:Transcriptional Activation; D014162:Transfection
D004268:DNA-Binding Proteins; D009687:Nuclear Proteins; D051757:PAX5 Transcription Factor; C497281:PAX5 protein, human; D011994:Recombinant Proteins; D014157:Transcription Factors; D015500:Chloramphenicol O-Acetyltransferase